Z Squared Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ZSQR Nasdaq 2836 ir.zsquaredinc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Z Squared Inc.

Z Squared Acquires Energized Arkansas Campus to Advance AI Infrastructure Strategy - Sep 9th, 2026 5:00 am
Z Squared Inc. Signs Definitive Agreement to Acquire 100% of Paradox Data and Its Union County Campus - Aug 3rd, 2026 5:00 am
Z Squared Inc. Provides Capital Structure Update - Jul 15th, 2026 7:06 am
Z Squared Inc. Appoints Jeffrey Harris as Chief Technology Officer - Jun 30th, 2026 5:00 am
Z Squared Raises Approximately $15.3 Million in Non-Debt Capital to Advance AI Infrastructure Strategy - Jun 29th, 2026 2:39 pm
Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000® - Jun 29th, 2026 5:00 am
Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power - Jun 25th, 2026 5:00 am
Z Squared to Participate in Maxim Group's AI Data Center Summit - Jun 9th, 2026 5:00 am
Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement to Support AI Infrastructure Buildout - Jun 4th, 2026 5:00 am
Z Squared, Inc. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes - May 27th, 2026 5:00 am